On March 22, 2024, OliX Pharmaceuticals, Inc closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,220 KRW | -0.59% | +1.67% | +4.39% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
38,050 KRW | +1.87% | +5.99% | 2.47B | ||
15,220 KRW | -0.59% | +1.67% | 183M | ||
12,320 KRW | +3.44% | +10.39% | 3.08B | ||
7,550 KRW | +3.00% | +5.59% | 2.87B | ||
1st Jan change | Capi. | |
---|---|---|
+4.39% | 183M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- A226950 Stock
- News OliX Pharmaceuticals, Inc
- OliX Pharmaceuticals, Inc announced that it has received KRW 14.7 billion in funding from a group of investors